| PERIOD ENDING | 28-Jun-08 | 29-Mar-08 | 29-Dec-07 | 29-Sep-07 | | Total Revenue | 21,140,300 | 21,326,000 | 21,942,400 | 20,495,200 | | Cost of Revenue | 16,767,100 | 17,033,000 | 17,491,600 | 16,300,000 | | | Gross Profit | 4,373,200 | 4,293,000 | 4,450,800 | 4,195,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,895,100 | 2,922,900 | 2,974,900 | 2,924,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,478,100 | 1,370,100 | 1,475,900 | 1,271,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,800 | 6,300 | 33,700 | (15,600) | | Earnings Before Interest And Taxes | 1,481,900 | 1,376,400 | 1,509,600 | 1,255,500 | | Interest Expense | 118,500 | 137,200 | 171,000 | 111,900 | | Income Before Tax | 1,363,400 | 1,239,200 | 1,338,600 | 1,143,600 | | Income Tax Expense | 539,900 | 490,700 | 523,600 | 454,100 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 823,500 | 748,500 | 815,000 | 689,500 | | | Non-recurring Events | | Discontinued Operations | (48,700) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 774,800 | 748,500 | 815,000 | 689,500 | | Preferred Stock And Other Adjustments | (3,600) | (3,500) | (3,800) | (3,400) | | | Net Income Applicable To Common Shares | $771,200 | $745,000 | $811,200 | $686,100 |
|
1.49% Nasdaq 
0.27%
Income Statement
